| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 48.58B | 70.20B | 51.67B | 47.57B | 44.47B | 40.69B |
| Gross Profit | 48.58B | 60.66B | 47.91B | 44.30B | 42.01B | 40.30B |
| EBITDA | 7.80B | 13.55B | 11.71B | 8.70B | 8.41B | 7.66B |
| Net Income | 6.26B | 8.59B | 7.50B | 6.22B | 5.49B | 4.08B |
Balance Sheet | ||||||
| Total Assets | 3.26T | 3.22T | 3.18T | 3.16T | 3.01T | 3.16T |
| Cash, Cash Equivalents and Short-Term Investments | 0.00 | 280.15B | 270.96B | 201.84B | 72.97B | 301.83B |
| Total Debt | 78.69B | 34.05B | 45.20B | 110.51B | 74.77B | 208.39B |
| Total Liabilities | 3.14T | 3.09T | 3.06T | 3.04T | 2.90T | 3.05T |
| Stockholders Equity | 119.52B | 126.50B | 116.37B | 122.56B | 108.76B | 115.78B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -1.18B | 20.36B | -26.20B | -190.17B | -4.59B |
| Operating Cash Flow | 0.00 | 2.37B | 22.94B | -24.61B | -188.82B | -3.58B |
| Investing Cash Flow | 0.00 | -16.11B | 95.41B | 14.54B | -43.72B | -67.45B |
| Financing Cash Flow | 0.00 | 22.00B | 18.00B | 143.86B | -1.18B | 86.57B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | ¥77.52B | 6.81 | ― | 2.34% | 3.68% | 26.06% | |
71 Outperform | ¥109.86B | 14.74 | ― | 3.35% | 26.92% | 35.22% | |
71 Outperform | ¥116.16B | 5.37 | ― | 3.05% | 49.84% | 156.03% | |
70 Outperform | ¥108.77B | 8.79 | ― | 2.49% | 12.95% | 16.69% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
67 Neutral | ¥93.93B | 11.37 | ― | 2.89% | 23.58% | 50.43% | |
65 Neutral | ¥87.68B | 9.19 | ― | 2.29% | 11.72% | 14.29% |